Systemic Sclerosis and Vascular Complications
Topadur Pharma AG focuses on systemic sclerosis with emphasis on digital ulcers, a painful ischemic wound manifestation affecting the fingertips.
- Digital ulcers in systemic sclerosis
- Ischemic wound management
- Fingertip ulceration
The sponsor’s clinical activity is centered on local treatment of ulcerated lesions associated with connective tissue disease.
Topical Wound Therapy
Its research includes topical administration of investigational products applied directly to ulcerated skin, with interest in local tolerability and safety.
- Local wound application
- Hydrogel formulation
- Skin and wound tolerability
This area reflects a therapeutic focus on direct treatment of cutaneous ulcers rather than systemic exposure.
Microvascular Injury
The sponsor’s trial activity is relevant to microvascular dysfunction and tissue ischemia, both central to ulcer formation in systemic sclerosis.
- Local ischemia
- Peripheral microcirculation
- Wound perfusion impairment
Clinical interest is directed toward lesions where compromised blood flow contributes to delayed healing and persistent tissue damage.
Dermatologic and Rheumatologic Interface
Topadur Pharma AG operates at the intersection of dermatology and rheumatology, addressing skin ulceration arising from an autoimmune connective tissue disorder.
- Autoimmune connective tissue disease
- Skin ulcer care
- Rheumatic disease complications
The sponsor’s clinical interest is concentrated on the management of ulcerative skin lesions linked to systemic autoimmune disease.
